Coronavirus (COVID-19)
Learn more
March 13, 2013
Location: The Hospital of Central Connecticut
A Phase II evaluation of Ixabepilone in the treatment of recurrent or persistent Leiomyosarcoma of the Uterus.
Get the latest healthcare news directly in your inbox.
Sign up for text alerts / Text MoreLife to 31996.